the podcast on
Access is opening up for Kiwis to a weight loss drug described as a game changer.
Wegovy, made by pharma-co Novo Nordisk, will arrive in pharmacies next week.
It's not funded by Pharmac, so users will have to pay and get a prescription for the weekly injectable.
Calocurb CEO Sarah Kennedy told Ryan Bridge that people need to be aware of both the cost of the drug and the side effect.
She says that over 70% of people using Wegovy will have gastrointestinal problems that range from nausea to diarrhoea, and over 70% of people regain the weight within a year.
Kennedy says lifestyle changes need to be made as well as taking the drug.
LISTEN ABOVE
Take your Radio, Podcasts and Music with you
Get the iHeart App
Get more of the radio, music and podcasts you love with the FREE iHeartRadio app. Scan the QR code to download now.
Download from the app stores
Stream unlimited music, thousands of radio stations and podcasts all in one app. iHeartRadio is easy to use and all FREE
